Prospective, randomized, placebo-controlled phase 2b trial of SurVaxM plus adjuvant temozolomide in newly diagnosed glioblastoma (SURVIVE).

Manmeet Singh Ahluwalia; David A. Reardon; Nicholas A. Butowski; Robert Aiken; David M. Peereboom; Vyshak Venur; Ajay Prakash Abad; Ahmed Belal; Danielle M. Casucci; Sheila A. Figel; Yazmin Odia; Zhijian Chen; Kaylyn Sinicrope; John A. Boockvar; Marissa Barbaro; Andrew J. Brenner; Brian D. Vaillant; Robert Alan Fenstermaker; Michael J. Ciesielski; Jing Xin Qiu

doi:10.1200/JCO.2026.44.16_suppl.TPS2106

Prospective, randomized, placebo-controlled phase 2b trial of SurVaxM plus adjuvant temozolomide in newly diagnosed glioblastoma (SURVIVE).

Manmeet Singh Ahluwalia
, David A. Reardon
, Nicholas A. Butowski
, Robert Aiken
, David M. Peereboom
, Vyshak Venur
, Ajay Prakash Abad
, Ahmed Belal
, Danielle M. Casucci
, Sheila A. Figel
, Yazmin Odia
, Zhijian Chen
, Kaylyn Sinicrope
, John A. Boockvar
, Marissa Barbaro
, Andrew J. Brenner
, Brian D. Vaillant
, Robert Alan Fenstermaker
, Michael J. Ciesielski
, Jing Xin Qiu

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	TPS2106-TPS2106
Journal	Journal of Clinical Oncology
Volume	44
DOIs	https://doi.org/10.1200/JCO.2026.44.16_suppl.TPS2106
State	Published - Jun 2026

ASJC Scopus Subject Areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.2026.44.16_suppl.TPS2106

Cite this

Ahluwalia, M. S., Reardon, D. A., Butowski, N. A., Aiken, R., Peereboom, D. M., Venur, V., Abad, A. P., Belal, A., Casucci, D. M., Figel, S. A., Odia, Y., Chen, Z., Sinicrope, K., Boockvar, J. A., Barbaro, M., Brenner, A. J., Vaillant, B. D., Fenstermaker, R. A., Ciesielski, M. J., & Qiu, J. X. (2026). Prospective, randomized, placebo-controlled phase 2b trial of SurVaxM plus adjuvant temozolomide in newly diagnosed glioblastoma (SURVIVE). Journal of Clinical Oncology, 44, TPS2106-TPS2106. https://doi.org/10.1200/JCO.2026.44.16_suppl.TPS2106

Ahluwalia, MS, Reardon, DA, Butowski, NA, Aiken, R, Peereboom, DM, Venur, V, Abad, AP, Belal, A, Casucci, DM, Figel, SA, Odia, Y, Chen, Z, Sinicrope, K, Boockvar, JA, Barbaro, M, Brenner, AJ, Vaillant, BD, Fenstermaker, RA, Ciesielski, MJ & Qiu, JX 2026, 'Prospective, randomized, placebo-controlled phase 2b trial of SurVaxM plus adjuvant temozolomide in newly diagnosed glioblastoma (SURVIVE).', Journal of Clinical Oncology, vol. 44, pp. TPS2106-TPS2106. https://doi.org/10.1200/JCO.2026.44.16_suppl.TPS2106

@article{f81b384e38be406384ca625b1ea43a4a,

title = "Prospective, randomized, placebo-controlled phase 2b trial of SurVaxM plus adjuvant temozolomide in newly diagnosed glioblastoma (SURVIVE).",

author = "Ahluwalia, \{Manmeet Singh\} and Reardon, \{David A.\} and Butowski, \{Nicholas A.\} and Robert Aiken and Peereboom, \{David M.\} and Vyshak Venur and Abad, \{Ajay Prakash\} and Ahmed Belal and Casucci, \{Danielle M.\} and Figel, \{Sheila A.\} and Yazmin Odia and Zhijian Chen and Kaylyn Sinicrope and Boockvar, \{John A.\} and Marissa Barbaro and Brenner, \{Andrew J.\} and Vaillant, \{Brian D.\} and Fenstermaker, \{Robert Alan\} and Ciesielski, \{Michael J.\} and Qiu, \{Jing Xin\}",

note = "Publisher Copyright: {\textcopyright} 2026 by American Society of Clinical Oncology",

year = "2026",

month = jun,

doi = "10.1200/JCO.2026.44.16\_suppl.TPS2106",

language = "English",

volume = "44",

pages = "TPS2106--TPS2106",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

}

TY - JOUR

T1 - Prospective, randomized, placebo-controlled phase 2b trial of SurVaxM plus adjuvant temozolomide in newly diagnosed glioblastoma (SURVIVE).

AU - Ahluwalia, Manmeet Singh

AU - Reardon, David A.

AU - Butowski, Nicholas A.

AU - Aiken, Robert

AU - Peereboom, David M.

AU - Venur, Vyshak

AU - Abad, Ajay Prakash

AU - Belal, Ahmed

AU - Casucci, Danielle M.

AU - Figel, Sheila A.

AU - Odia, Yazmin

AU - Chen, Zhijian

AU - Sinicrope, Kaylyn

AU - Boockvar, John A.

AU - Barbaro, Marissa

AU - Brenner, Andrew J.

AU - Vaillant, Brian D.

AU - Fenstermaker, Robert Alan

AU - Ciesielski, Michael J.

AU - Qiu, Jing Xin

PY - 2026/6

Y1 - 2026/6

UR - https://www.scopus.com/pages/publications/105041999793

UR - https://www.scopus.com/pages/publications/105041999793#tab=citedBy

U2 - 10.1200/JCO.2026.44.16_suppl.TPS2106

DO - 10.1200/JCO.2026.44.16_suppl.TPS2106

M3 - Article

AN - SCOPUS:105041999793

SN - 0732-183X

VL - 44

SP - TPS2106-TPS2106

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -

Prospective, randomized, placebo-controlled phase 2b trial of SurVaxM plus adjuvant temozolomide in newly diagnosed glioblastoma (SURVIVE).

ASJC Scopus Subject Areas

Access to Document

Other files and links

Cite this